Executive Summary: The Global Waldenstrom’s Macroglobulinemia (WM) Treatment Market size was valued at USD 160.50 million in 2024 and is expected to reach USD 228.70 million by 2032, at a CAGR of 5.20% during the forecast period. This growth is driven by factors such as the increasing prevalence of Waldenstrom's Macroglobulinemia (WM), rising demand for targeted therapies, and the...